By Lauran Neergaard

The U.S. could soon be giving at least a million COVID-19 vaccinations a day despite the sluggish start, Dr. Anthony Fauci said Tuesday, even as he warned of a dangerous next few weeks as the coronavirus surges.

The slow pace is frustrating health officials and a desperate public alike, with only about a third of the first supplies shipped to states used as of Tuesday morning, just over three weeks into the vaccination campaign.

“Any time you start a big program, there’s always glitches. I think the glitches have been worked out,” the nation's top infectious disease expert told The Associated Press.

Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Now, with the holidays over, “once you get rolling and get some momentum, I think we can achieve 1 million a day or even more,” Fauci said. He called President-elect Joe Biden’s goal of 100 million vaccinations in his first 100 days “a very realistic, important, achievable goal.”

It’s an optimistic prediction considering the logistical hurdles facing states and counties as they struggle to administer rationed vaccine supplies amid rising COVID-19 hospitalizations. Fauci pointed to California’s swamped hospitals and exhausted workers even before holiday travel and family gatherings added fuel to the outbreak.

Fauci estimated that between 70% and 85% of the U.S. population will need to be vaccinated to achieve “herd immunity,” meaning enough people are protected that it’s difficult for the virus to continue spreading. That translates to as many as 280 million people.

He said he is hoping to achieve that by the start of next fall.

The coronavirus has killed more than 356,000 Americans, and the next few weeks could bring another jump in infections nationally that “could make matters even worse,” Fauci said.

The Trump administration had promised to provide states enough vaccine for 20 million people in December and fell short even as states struggled with their role — getting shots into people’s arms, starting mostly with health care workers and nursing home residents.

According to the Centers for Disease Control and Prevention, roughly 4.8 million doses of more than 17 million delivered had been used by Tuesday morning. That is probably an undercount because of delays in reporting, but it is far fewer than experts had hoped.

Still, Fauci pointed to a celebrated moment in history to back up his projection of ramped-up inoculations: In 1947, New York City vaccinated more than 6 million people against a smallpox outbreak in less than a month — and “one of them was me as a 6-year-old boy."

If a single city could do such mass vaccinations in weeks, “this is not something that is far-fetched” for an entire country, he said. “You can use school auditoriums, you can use stadiums. You can really ramp up the contribution of pharmacies.”

At that stepped-up pace, the country could see an impact on infections as early as spring — and hopefully by early fall, “you could start thinking about returning to some degree of normality,” Fauci said.

Amid mounting frustration over the slow vaccine rollout, governors and other politicians are talking tough and in some cases proposing to bend the rules to get people vaccinated more quickly. Health care workers and nursing home patients are still getting priority in most places.

New York Gov. Andrew Cuomo threatened to fine hospitals that don’t use their vaccine allotments fast enough, saying: “Move it quickly. We’re serious.”

Gov. Henry McMaster of South Carolina said hospitals and health workers have until Jan. 15 to get a shot or they will have to “move to the back of the line.” As of Monday, the state had given out less than half its initial allotment of the Pfizer vaccine to about 43,000 people.

In North Carolina, Gov. Roy Cooper called in the National Guard to help speed things up.

In California, where just 1% of the population has been vaccinated, Gov. Gavin Newsom said he wants to give providers the flexibility to dispense shots to people not on the priority list if doses are in danger of going to waste.

New York’s mayor suggested vaccine eligibility be widened to get things moving.

There’s no sign yet that a more contagious variant of the coronavirus first found in Britain — which forced England into another national lockdown on Tuesday — will outwit the vaccines. Fauci’s colleagues at the National Institutes of Health are doing their own testing to be sure, just as vaccine manufacturers are.

While the variant has been found in several states “it is certainly not dominant,” Fauci said. “We don’t know where it’s going. We’re going to follow it very carefully.”

The more contagious virus makes it even more important that people follow the public health precautions Fauci has preached for months, including wearing a mask, keeping your distance, and avoiding crowds.

In addition, scientists are warily watching a different variant found in South Africa but not yet reported in the U.S. There have been reports that the mutation might make treatments called monoclonal antibodies less likely to work. Fauci said he couldn’t confirm that, but U.S. scientists will investigate.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
An Omicron Christmas, Student Loans & Love, Hate, Ate
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer COVID Treatment Pill Gets FDA Authorization
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
Semiconductor Industry Warns Shortage Could Last Deep Into 2022
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Nomi Health Closes $110 Million to Further Scale Its Direct Healthcare Model Nationwide
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
Delta Airlines CEO Calls for Shortened Quarantine Times Amid Staffing Shortage
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
NASA to Launch The James Webb Space Telescope on Christmas Eve
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
The Importance of COVID-19 Tests in the Age of Omicron
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
Load More